Sean will study the molecular basis for modulation of GPCR signalling by allosteric modulators.
Sean Cullum joins the Veprintsev lab
Updated: Dec 2, 2019
top of page
Search
Recent Posts
See AllThe goal of this project is to develop quantum biosensors for drug discovery at single molecule level. Quantum sensing detects changes in motion and electric and magnetic fields at the atomic level. I
Short read: The project is focused on identification of autoantibodies against a panel of inflammation related GPCRs in patient samples and evaluation of specific therapeutic interventions counteracti
BBSRC-funded PhD project in the group of Prof. Dmitry Veprintsev at the University of Nottingham. This is a joint project with Dr. David Scott, Research Complex Harwell/UoN, and Dr. Aditi Borkar/UoN.
Post: Blog2_Post
bottom of page